US Stock MarketDetailed Quotes

SRNE Sorrento Therapeutics

Watchlist
  • 0.014
  • -0.001-6.67%
15min DelayClose May 2 16:00 ET
7.72MMarket Cap-12P/E (TTM)

Sorrento Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
31.28%-55.66M
40.67%-49.46M
-4.27%-293.86M
5.27%-68.34M
26.40%-61.17M
-3.15%-80.99M
-73.46%-83.36M
-76.65%-281.82M
-76.51%-72.14M
-95.14%-83.11M
Net income from continuing operations
50.59%-108.44M
-281.42%-154.63M
-34.63%-577.76M
-56.78%-227.11M
24.48%-90.63M
-31.66%-219.48M
-1,776.59%-40.54M
-36.49%-429.14M
-98.10%-144.86M
-37.75%-120M
Operating gains losses
-98.18%1.8M
121.76%15.37M
207.31%68.02M
79.46%57.98M
-218.47%-17.91M
52.13%98.59M
21.60%-70.64M
-56.76%22.13M
4,872.38%32.31M
865.45%15.12M
Depreciation and amortization
11.03%3.59M
9.85%3.62M
6.28%13.25M
17.28%3.35M
-5.33%3.36M
3.12%3.24M
13.02%3.3M
13.22%12.46M
28.96%2.86M
13.07%3.55M
Deferred tax
-574.27%-11.85M
958.38%11.49M
94.89%-1.84M
96.62%-1.15M
98.80%-11K
-152.08%-1.76M
595.89%1.09M
-1,590.68%-35.93M
-24,968.38%-34.09M
---918K
Other non cash items
113.49%10.31M
52.97%11.13M
-204.68%-64.12M
-89.13%4.39M
-95.48%611K
-5,119.32%-76.39M
25.00%7.28M
2.79%61.25M
513.27%40.38M
-64.84%13.53M
Change In working capital
485.81%33.45M
761.67%30.64M
2,591.97%69.55M
406.98%43.57M
260.71%24.91M
271.37%5.71M
-162.19%-4.63M
-173.47%-2.79M
39.43%8.59M
-212.33%-15.5M
-Change in receivables
-272.81%-6.21M
65.78%-2.05M
-92.09%-5.68M
87.70%-278K
-511.61%-3.01M
673.96%3.59M
-644.96%-5.98M
-181.35%-2.96M
-206.23%-2.26M
175.62%732K
-Change in inventory
90.77%-498K
77.71%-1.33M
-51.53%-9.51M
-490.58%-5.01M
350.78%6.88M
-97.29%-5.4M
-11,823.53%-5.98M
-509.66%-6.28M
---849K
---2.74M
-Change in prepaid assets
-48.90%3.03M
107.99%131K
218.46%6.8M
142.04%2.15M
128.92%374K
2,317.23%5.92M
-276.53%-1.64M
-216.89%-5.74M
-1,672.92%-5.11M
-143.45%-1.29M
-Change in payables and accrued expense
2,055.97%40.79M
222.34%33.85M
1,040.71%191.16M
1,616.65%156.84M
4.80%21.93M
872.24%1.89M
63.63%10.5M
20,847.50%16.76M
-303.72%-10.34M
459.39%20.93M
-Change in other working capital
-1,123.75%-3.66M
102.94%45K
-2,375.88%-113.22M
-1,967.20%-110.68M
-16.83%-715K
-155.27%-299K
-279.58%-1.53M
-173.01%-4.57M
-16,631.25%-5.35M
46.64%-612K
Cash from discontinued investing activities
Operating cash flow
31.28%-55.66M
40.67%-49.46M
-4.27%-293.86M
5.27%-68.34M
26.40%-61.17M
-3.15%-80.99M
-73.46%-83.36M
-76.65%-281.82M
-76.51%-72.14M
-95.14%-83.11M
Investing cash flow
Cash flow from continuing investing activities
91.90%-140K
112.32%1.68M
-135.72%-28.52M
-128.30%-5.03M
-249.96%-8.09M
-102.20%-1.73M
-581.16%-13.66M
300.00%79.85M
80.68%-2.21M
121.39%5.4M
Net PPE purchase and sale
94.82%-140K
96.68%-86K
-53.95%-13.66M
-104.80%-4.52M
-226.38%-3.84M
22.56%-2.71M
-30.04%-2.59M
-35.89%-8.87M
17.82%-2.21M
59.06%-1.18M
Net business purchase and sale
--0
--0
58.78%-14.86M
21.54%-510K
80.97%-4.26M
107.51%977K
-92,158.33%-11.07M
-7.95%-36.05M
97.91%-650K
-69,809.38%-22.37M
Net investment purchase and sale
--0
--1.77M
--0
--0
--0
--0
--0
--124.77M
--654K
--28.94M
Cash from discontinued investing activities
Investing cash flow
91.90%-140K
112.32%1.68M
-135.72%-28.52M
-128.30%-5.03M
-249.96%-8.09M
-102.20%-1.73M
-581.16%-13.66M
300.00%79.85M
80.68%-2.21M
121.39%5.4M
Financing cash flow
Cash flow from continuing financing activities
112.62%88.81M
-64.70%61.2M
71.90%311.72M
-64.60%25.08M
78.48%71.5M
19.15%41.77M
390.34%173.37M
4.07%181.33M
712.10%70.86M
-66.01%40.06M
Net issuance payments of debt
245.34%91.64M
334.13%38.23M
-156.84%-92.24M
-2,278.62%-38.02M
100.73%23K
-269.35%-63.05M
150.46%8.81M
80.79%-35.91M
102.82%1.75M
-224.84%-3.14M
Net common stock issuance
-102.10%-2.19M
-86.03%22.97M
99.35%402.33M
-6.94%62.3M
70.47%71.46M
105.21%104.15M
289.57%164.43M
-23.22%201.83M
34.28%66.95M
-34.26%41.92M
Proceeds from stock option exercised by employees
10.70%745K
--0
-92.23%1.2M
-82.77%373K
-98.44%20K
-51.13%673K
-98.75%132K
-84.32%15.42M
300.18%2.17M
-97.67%1.28M
Net other financing activities
----
----
--426K
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
112.62%88.81M
-64.70%61.2M
71.90%311.72M
-64.60%25.08M
78.48%71.5M
19.15%41.77M
390.34%173.37M
4.07%181.33M
712.10%70.86M
-66.01%40.06M
Net cash flow
Beginning cash position
-66.35%37.66M
-35.54%23.63M
-35.06%36.67M
77.89%70.69M
-8.99%70.35M
168.50%111.91M
-35.06%36.67M
-30.09%56.46M
-66.94%39.74M
11.39%77.29M
Current changes in cash
180.63%33.01M
-82.42%13.42M
48.37%-10.66M
-1,285.71%-48.29M
105.94%2.24M
-216.30%-40.95M
619.14%76.35M
18.15%-20.64M
94.54%-3.49M
-175.26%-37.66M
Effect of exchange rate changes
-49.35%-920K
154.35%600K
-381.61%-2.37M
198.80%1.24M
-1,994.00%-1.89M
-250.98%-616K
-1,280.00%-1.1M
-7.87%843K
182.31%415K
-86.74%100K
End cash Position
-0.85%69.75M
-66.35%37.66M
-35.54%23.63M
-35.54%23.63M
77.89%70.69M
-8.99%70.35M
168.50%111.91M
-35.06%36.67M
-35.06%36.67M
-66.94%39.74M
Free cash flow
33.33%-55.8M
42.36%-49.55M
-5.79%-307.51M
2.00%-72.86M
22.88%-65.01M
-2.05%-83.69M
-71.73%-85.95M
-75.05%-290.69M
-250.16%-74.35M
-24.34%-84.29M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 31.28%-55.66M40.67%-49.46M-4.27%-293.86M5.27%-68.34M26.40%-61.17M-3.15%-80.99M-73.46%-83.36M-76.65%-281.82M-76.51%-72.14M-95.14%-83.11M
Net income from continuing operations 50.59%-108.44M-281.42%-154.63M-34.63%-577.76M-56.78%-227.11M24.48%-90.63M-31.66%-219.48M-1,776.59%-40.54M-36.49%-429.14M-98.10%-144.86M-37.75%-120M
Operating gains losses -98.18%1.8M121.76%15.37M207.31%68.02M79.46%57.98M-218.47%-17.91M52.13%98.59M21.60%-70.64M-56.76%22.13M4,872.38%32.31M865.45%15.12M
Depreciation and amortization 11.03%3.59M9.85%3.62M6.28%13.25M17.28%3.35M-5.33%3.36M3.12%3.24M13.02%3.3M13.22%12.46M28.96%2.86M13.07%3.55M
Deferred tax -574.27%-11.85M958.38%11.49M94.89%-1.84M96.62%-1.15M98.80%-11K-152.08%-1.76M595.89%1.09M-1,590.68%-35.93M-24,968.38%-34.09M---918K
Other non cash items 113.49%10.31M52.97%11.13M-204.68%-64.12M-89.13%4.39M-95.48%611K-5,119.32%-76.39M25.00%7.28M2.79%61.25M513.27%40.38M-64.84%13.53M
Change In working capital 485.81%33.45M761.67%30.64M2,591.97%69.55M406.98%43.57M260.71%24.91M271.37%5.71M-162.19%-4.63M-173.47%-2.79M39.43%8.59M-212.33%-15.5M
-Change in receivables -272.81%-6.21M65.78%-2.05M-92.09%-5.68M87.70%-278K-511.61%-3.01M673.96%3.59M-644.96%-5.98M-181.35%-2.96M-206.23%-2.26M175.62%732K
-Change in inventory 90.77%-498K77.71%-1.33M-51.53%-9.51M-490.58%-5.01M350.78%6.88M-97.29%-5.4M-11,823.53%-5.98M-509.66%-6.28M---849K---2.74M
-Change in prepaid assets -48.90%3.03M107.99%131K218.46%6.8M142.04%2.15M128.92%374K2,317.23%5.92M-276.53%-1.64M-216.89%-5.74M-1,672.92%-5.11M-143.45%-1.29M
-Change in payables and accrued expense 2,055.97%40.79M222.34%33.85M1,040.71%191.16M1,616.65%156.84M4.80%21.93M872.24%1.89M63.63%10.5M20,847.50%16.76M-303.72%-10.34M459.39%20.93M
-Change in other working capital -1,123.75%-3.66M102.94%45K-2,375.88%-113.22M-1,967.20%-110.68M-16.83%-715K-155.27%-299K-279.58%-1.53M-173.01%-4.57M-16,631.25%-5.35M46.64%-612K
Cash from discontinued investing activities
Operating cash flow 31.28%-55.66M40.67%-49.46M-4.27%-293.86M5.27%-68.34M26.40%-61.17M-3.15%-80.99M-73.46%-83.36M-76.65%-281.82M-76.51%-72.14M-95.14%-83.11M
Investing cash flow
Cash flow from continuing investing activities 91.90%-140K112.32%1.68M-135.72%-28.52M-128.30%-5.03M-249.96%-8.09M-102.20%-1.73M-581.16%-13.66M300.00%79.85M80.68%-2.21M121.39%5.4M
Net PPE purchase and sale 94.82%-140K96.68%-86K-53.95%-13.66M-104.80%-4.52M-226.38%-3.84M22.56%-2.71M-30.04%-2.59M-35.89%-8.87M17.82%-2.21M59.06%-1.18M
Net business purchase and sale --0--058.78%-14.86M21.54%-510K80.97%-4.26M107.51%977K-92,158.33%-11.07M-7.95%-36.05M97.91%-650K-69,809.38%-22.37M
Net investment purchase and sale --0--1.77M--0--0--0--0--0--124.77M--654K--28.94M
Cash from discontinued investing activities
Investing cash flow 91.90%-140K112.32%1.68M-135.72%-28.52M-128.30%-5.03M-249.96%-8.09M-102.20%-1.73M-581.16%-13.66M300.00%79.85M80.68%-2.21M121.39%5.4M
Financing cash flow
Cash flow from continuing financing activities 112.62%88.81M-64.70%61.2M71.90%311.72M-64.60%25.08M78.48%71.5M19.15%41.77M390.34%173.37M4.07%181.33M712.10%70.86M-66.01%40.06M
Net issuance payments of debt 245.34%91.64M334.13%38.23M-156.84%-92.24M-2,278.62%-38.02M100.73%23K-269.35%-63.05M150.46%8.81M80.79%-35.91M102.82%1.75M-224.84%-3.14M
Net common stock issuance -102.10%-2.19M-86.03%22.97M99.35%402.33M-6.94%62.3M70.47%71.46M105.21%104.15M289.57%164.43M-23.22%201.83M34.28%66.95M-34.26%41.92M
Proceeds from stock option exercised by employees 10.70%745K--0-92.23%1.2M-82.77%373K-98.44%20K-51.13%673K-98.75%132K-84.32%15.42M300.18%2.17M-97.67%1.28M
Net other financing activities ----------426K----------------------------
Cash from discontinued financing activities
Financing cash flow 112.62%88.81M-64.70%61.2M71.90%311.72M-64.60%25.08M78.48%71.5M19.15%41.77M390.34%173.37M4.07%181.33M712.10%70.86M-66.01%40.06M
Net cash flow
Beginning cash position -66.35%37.66M-35.54%23.63M-35.06%36.67M77.89%70.69M-8.99%70.35M168.50%111.91M-35.06%36.67M-30.09%56.46M-66.94%39.74M11.39%77.29M
Current changes in cash 180.63%33.01M-82.42%13.42M48.37%-10.66M-1,285.71%-48.29M105.94%2.24M-216.30%-40.95M619.14%76.35M18.15%-20.64M94.54%-3.49M-175.26%-37.66M
Effect of exchange rate changes -49.35%-920K154.35%600K-381.61%-2.37M198.80%1.24M-1,994.00%-1.89M-250.98%-616K-1,280.00%-1.1M-7.87%843K182.31%415K-86.74%100K
End cash Position -0.85%69.75M-66.35%37.66M-35.54%23.63M-35.54%23.63M77.89%70.69M-8.99%70.35M168.50%111.91M-35.06%36.67M-35.06%36.67M-66.94%39.74M
Free cash flow 33.33%-55.8M42.36%-49.55M-5.79%-307.51M2.00%-72.86M22.88%-65.01M-2.05%-83.69M-71.73%-85.95M-75.05%-290.69M-250.16%-74.35M-24.34%-84.29M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg